08:55 AM EDT, 10/04/2024 (MT Newswires) -- Health care stocks were higher pre-bell Friday as the Health Care Select Sector SPDR Fund (XLV) rose 0.3% and the iShares Biotechnology ETF (IBB) was recently up 0.8%.

Summit Therapeutics ( SMMT ) shares rose by over 13% after the company said it completed enrollment in a phase 3 clinical trial of ivonescimab in North America, Europe, and China, with topline data expected in mid-2025.